ATE124262T1 - Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung. - Google Patents

Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.

Info

Publication number
ATE124262T1
ATE124262T1 AT92903046T AT92903046T ATE124262T1 AT E124262 T1 ATE124262 T1 AT E124262T1 AT 92903046 T AT92903046 T AT 92903046T AT 92903046 T AT92903046 T AT 92903046T AT E124262 T1 ATE124262 T1 AT E124262T1
Authority
AT
Austria
Prior art keywords
host cell
colonition
inhibit bacterial
cell phospholipids
phospholipids
Prior art date
Application number
AT92903046T
Other languages
English (en)
Inventor
Howard C Krivan
Bo Nilsson
Clifford A Lingwood
Original Assignee
Microcarb Inc
Hsc Research And Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microcarb Inc, Hsc Research And Dev filed Critical Microcarb Inc
Application granted granted Critical
Publication of ATE124262T1 publication Critical patent/ATE124262T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92903046T 1990-12-21 1991-12-20 Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung. ATE124262T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63237290A 1990-12-21 1990-12-21

Publications (1)

Publication Number Publication Date
ATE124262T1 true ATE124262T1 (de) 1995-07-15

Family

ID=24535267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903046T ATE124262T1 (de) 1990-12-21 1991-12-20 Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.

Country Status (9)

Country Link
US (1) US5411948A (de)
EP (1) EP0563256B1 (de)
JP (1) JP3042713B2 (de)
AT (1) ATE124262T1 (de)
CA (1) CA2098842C (de)
DE (1) DE69110906T2 (de)
DK (1) DK0563256T3 (de)
HK (1) HK1007679A1 (de)
WO (1) WO1992011015A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798117A (en) * 1992-04-24 1998-08-25 Biocompatibles Limited Method of reducing microorganism adhesion
CA2067603A1 (en) * 1992-04-29 1993-10-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
WO1995032716A1 (en) * 1994-05-31 1995-12-07 Haar, Jonathan Methods and products for the control of pathogenic bacteria
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
FR2742054B1 (fr) * 1995-12-06 1998-01-09 Synthelabo Compositions pharmaceutiques contenant un agent anti-inflammatoire et des ceramides vegetales
AU6084598A (en) * 1997-02-26 1998-09-18 Hsc Research And Development Limited Partnership Antibiotic-ligand conjugates and methods of use thereof
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
ATE340571T1 (de) * 2000-01-18 2006-10-15 Univ Mcgill Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen
GB0114940D0 (en) * 2001-06-19 2001-08-08 Chiron Spa Gene expression during meningococcus adhesion
US6869602B2 (en) * 2002-02-20 2005-03-22 The United States Of America As Represented By The Secretary Of The Army Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells
TWI902231B (zh) * 2024-04-22 2025-10-21 國立臺灣大學醫學院附設醫院 胃幽門螺旋桿菌的樣本保存與抗藥基因型檢測的試劑與方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092121B1 (de) * 1982-04-12 1987-12-16 Board Of Regents, The University Of Texas System Verfahren und Zusammensetzungen zur Behandlung von Magen- und Darm-Ulcus
US4666893A (en) 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
SE8501613D0 (sv) * 1985-04-01 1985-04-01 Bio Carb Ab Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Also Published As

Publication number Publication date
EP0563256A1 (de) 1993-10-06
CA2098842A1 (en) 1992-06-22
EP0563256B1 (de) 1995-06-28
DK0563256T3 (da) 1995-08-28
DE69110906D1 (de) 1995-08-03
DE69110906T2 (de) 1995-11-16
US5411948A (en) 1995-05-02
JPH06511469A (ja) 1994-12-22
JP3042713B2 (ja) 2000-05-22
WO1992011015A1 (en) 1992-07-09
CA2098842C (en) 2005-06-14
HK1007679A1 (en) 1999-04-23

Similar Documents

Publication Publication Date Title
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
ATE347585T1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
IT1217828B (it) Dispositivo di fermentazione per la coltura aerobica di microorganismi
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ATE124262T1 (de) Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.
DE69227392D1 (de) Serumfreies Medium zur Züchtung von Tierzellen
DE69406662D1 (de) Einsätze zur verwendung bei der gewebekultur
IT1251203B (it) Procedimento e apparecchiatura per la fermentazione di amminoacidi
BG104726A (en) Novel derivatives of the dihydroxyhexanoic acid
DE69530409D1 (de) Epithelzellen enthaltendes biomaterial und ihre verwendung als transplantat
DE69631972D1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
FI20095510L (fi) Suuren solutiheyden bakteerifermentaatioviljelmä
DE69725882D1 (de) Adenovirus e4 proteine für induktion von zelltod
AU4836497A (en) Enhancing keratinocyte migration and proliferation
FI963373A7 (fi) Ruumiin ulkopuolinen soluviljelmä ja transplantaatiopakkauksia
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
ATE201908T1 (de) Verfahren zur herstellung von riboflavin mittels mikroorganismen mit veränderter isocitratlyase- aktivität
DE3778158D1 (de) Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants.
AU4299696A (en) Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
ATE124449T1 (de) Mikrobiologisches verfahren zur herstellung von hydroxylierten heterocyclen.
ATE106097T1 (de) Verwendung von gyrasehemmern zur dekontamination von mycoplasma-infizierten zellkulturen.
DE69634363D1 (de) Vorläufer von normalen neuralen epithelzellen
DE3787653D1 (de) Biotechnischer monitor zur kontinuierlichen bestimmung von schadwirkungen auf mikroorganismen in wasser.
ES2117717T3 (es) Tratamiento de tumores con factores neurotroficos e inhibidores de la proliferacion celular.
DE3854472D1 (de) Erhaltung der Viabilität von Mikroorganismen zur Anwendung in mikrobiellen Inokulantien.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties